NewsPromising clinical results from use of Episealer® accepted for presentation at the 35th AGA Congress in Austria

The presentation “Patient-specific miniature surface replacement in refractory focal (osteo) chondral knee joint lesions of the middle-aged patient – 2 year results” by Dr. Clemens Kösters from the Maria-Josef-Hospital, Greven, Germany has been accepted for the 35th AGA Congress, to be held in Linz, Austria in September 2018. The presentation will focus on 2-years’ follow-up of surgeries performed in Germany with the Episealer® knee implant.

“Our patient population exceeding 24 months post-op is increasing and we are delighted with the fact that clinical results from the use of Episealer® knee implants will be presented at the AGA Congress. The AGA Congress is of great importance and this is a significant step for us in the Germany-Austria-Switzerland region” says Pål Ryfors, CEO of Episurf Medical.

For more  information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com